# Diazoxide Suppression Test P&F Study

> **NCT06606327** · PHASE1 · RECRUITING · sponsor: **Columbia University** · enrollment: 10 (estimated)

## Conditions studied

- Insulin Resistance
- Hyperinsulinemia
- Obesity

## Interventions

- **DRUG:** Diazoxide, 3 mg/kg per dose

## Key facts

- **NCT ID:** NCT06606327
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-23
- **Primary completion:** 2027-11
- **Final completion:** 2028-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-12-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06606327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06606327, "Diazoxide Suppression Test P&F Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06606327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*